We are pleased to see this litigation moving forward. Our Firm continues to receive inquiries from individuals seeking to file Biomet hip lawsuits for injuries allegedly caused by the M2a Magnum hip implant.
New York, NY (PRWEB) April 26, 2013
Biomet hip lawsuits pending in the U.S. District Court, Northern District of Indiana, continue to move forward, Bernstein Liebhard LLP reports. Records indicate that a Case Management Conference was convened by the Court on April 22nd, at which time issues involving discovery and depositions were addressed. The Court also scheduled the next Status Conference in the Biomet hip replacement litigation for June 17, 2013. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“We are pleased to see this litigation moving forward. Our Firm continues to receive inquiries from individuals seeking to file Biomet hip lawsuits for injuries allegedly caused by the M2a Magnum hip implant,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is actively filing claims in the federal Biomet hip replacement litigation, and continues to offer free legal evaluations to individuals who experienced complications allegedly from the Biomet M2a Magnum hip.
Biomet Hip Lawsuits
All of claims pending in the federal Biomet hip replacement litigation allege the metal-on-metal design of the M2a Magnum hip system can generate high levels of metal ions, leading to metallosis in the surrounding tissue and early failure of the device. Metal-on-metal hip replacements are currently being reviewed by the U.S. Food & Drug Administration (FDA), which in January advised doctors to consider metal ion testing for all-metal hip replacement patients who are experiencing symptoms of a failing implant, including pain, swelling, loosening of the implant, or change in the ability to walk. The FDA also proposed an order requiring manufacturers of metal-on-metal total hip replacement systems to submit premarket approval (PMA) applications, which would make them ineligible for 510(k) clearance.*
According to Health Digest News, the Consumers Union announced last week that it had sent a Comment Letter to the FDA urging the agency to adopt the rule it proposed in January. The letter, which was signed by 11,000 consumers, asserted that thousands of patients had been seriously harmed by metal-on-metal hip replacement devices that were never properly tested before being approved by the FDA.**
Biomet hip replacement recipients who allegedly suffered metallosis, hip implant failure, and other serious complications as a result of a Biomet M2a Magnum device may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. A wealth of information about Biomet hip lawsuits is available at Bernstein Liebhard’s website. For additional information, please contact one of our attorneys today by calling 1-877-779-1414.
About Bernstein Liebhard
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414 Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP